Concepedia

Boris Brill

BB

20

Publications

771

Citations

18

H-Index

2004

Active since

Affiliations

Georg Speyer Haus(Current)

Goethe University Frankfurt

Heidelberg University

German Cancer Research Center

Deutschen Konsortium für Translationale Krebsforschung

Boris Brill is an author at Georg Speyer Haus specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2004–2020

20

Publications

20

A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

Juliane Wagner, Viktoria Pfannenstiel, Anja Waldmann et al. · Frontiers in Immunology · 2017 · 105 citations · Full text

Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction

Dorotée Julia Trembinski, Diewertje I. Bink, Kosta Theodorou et al. · Nature Communications · 2020 · 102 citations · Full text

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells

Nicole Kiweler, Boris Brill, Matthias Wirth et al. · Archives of Toxicology · 2018 · 71 citations

, , +10

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Afsar Mian, Alireza Rafiei, Isabella Haberbosch et al. · Leukemia · 2014 · 64 citations

, , +9

Cytokine-Regulated GADD45G Induces Differentiation and Lineage Selection in Hematopoietic Stem Cells

Frederic B. Thalheimer, Susanne Wingert, Pangrazio De Giacomo et al. · Stem Cell Reports · 2014 · 44 citations · Full text

Rows per page

1–5 of 20